The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Malenka Robert C. | Director | Sell(S) | 736 | $18.15 | $13K |
| Feb 23, 2026 | Malenka Robert C. | Director | Sell(S) | 11K | $18.39 | $198K |
| Feb 23, 2026 | Malenka Robert C. | Director | Sell(S) | 476 | $19.06 | $9K |
| Feb 20, 2026 | Pavlov George | Director | Buy(P) | 10K | $17.86 | $177K |
| Feb 20, 2026 | Malenka Robert C. | Director | Sell(S) | 2K | $18.03 | $40K |
| Feb 19, 2026 | Pavlov George | Director | Buy(P) | 4K | $17.57 | $78K |
| Feb 18, 2026 | Pavlov George | Director | Buy(P) | 11K | $17.48 | $186K |
| Feb 13, 2026 | Malenka Robert C. | Director | Sell(S) | 12K | $18.21 | $221K |
| Feb 11, 2026 | Malenka Robert C. | Director | Sell(S) | 241 | $18.00 | $4K |
| Feb 10, 2026 | Garnett Timothy John | Director | Buy(P) | 14K | $17.89 | $253K |
| Feb 10, 2026 | Malenka Robert C. | Director | Sell(S) | 7K | $18.12 | $120K |
| Feb 5, 2026 | Kroeger Christopher A. | Chief Executive Officer, Director | Grant(A) | 23K | — | $0 |
| Feb 5, 2026 | Kroeger Christopher A. | Chief Executive Officer, Director | Grant(A) | 94K | — | $0 |
| Feb 5, 2026 | Gillis Jonathan | CAAO and PAO | Grant(A) | 6K | — | $0 |
| Feb 5, 2026 | Gillis Jonathan | CAAO and PAO | Grant(A) | 24K | — | $0 |
| Feb 5, 2026 | Lillie James Woodruff | Chief Scientific Officer | Grant(A) | 8K | — | $0 |
| Feb 5, 2026 | Lillie James Woodruff | Chief Scientific Officer | Grant(A) | 31K | — | $0 |
| Feb 5, 2026 | Hanson Kristopher | General Counsel | Grant(A) | 8K | — | $0 |
| Feb 5, 2026 | Hanson Kristopher | General Counsel | Grant(A) | 31K | — | $0 |
| Feb 5, 2026 | Foff Erin Pennock | Chief Medical Officer | Grant(A) | 13K | — | $0 |
| Feb 5, 2026 | Foff Erin Pennock | Chief Medical Officer | Grant(A) | 54K | — | $0 |
| Feb 5, 2026 | Kreitzer Anatol | Chief Discovery Officer | Grant(A) | 6K | — | $0 |
| Feb 5, 2026 | Kreitzer Anatol | Chief Discovery Officer | Grant(A) | 24K | — | $0 |
| Feb 5, 2026 | Setia Vishwas | Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Feb 5, 2026 | Setia Vishwas | Chief Financial Officer | Grant(A) | 31K | — | $0 |
| Feb 3, 2026 | Malenka Robert C. | Director | Sell(S) | 1 | $18.00 | $18 |
| Feb 2, 2026 | Malenka Robert C. | Director | Sell(S) | 7K | $18.02 | $127K |
| Jan 30, 2026 | Malenka Robert C. | Director | Sell(S) | 7K | $18.11 | $120K |
| Jan 29, 2026 | Malenka Robert C. | Director | Sell(S) | 21K | $18.55 | $394K |
| Jan 28, 2026 | Malenka Robert C. | Director | Sell(S) | 664 | $19.05 | $13K |
| Jan 28, 2026 | Malenka Robert C. | Director | Sell(S) | 6K | $18.61 | $109K |
| Jan 27, 2026 | Kroeger Christopher A. | Chief Executive Officer, Director | Tax withholding(F) | 204K | $17.98 | $3.7M |
| Jan 27, 2026 | Gillis Jonathan | CAAO and PAO | Tax withholding(F) | 22K | $17.98 | $396K |
| Jan 27, 2026 | Lillie James Woodruff | Chief Scientific Officer | Tax withholding(F) | 45K | $17.98 | $810K |
| Jan 27, 2026 | Hanson Kristopher | General Counsel | Tax withholding(F) | 26K | $17.98 | $468K |
| Jan 27, 2026 | Foff Erin Pennock | Chief Medical Officer | Tax withholding(F) | 45K | $17.98 | $802K |
| Jan 27, 2026 | Kreitzer Anatol | Chief Discovery Officer | Tax withholding(F) | 42K | $17.98 | $757K |
| Jan 27, 2026 | Setia Vishwas | Chief Financial Officer | Tax withholding(F) | 33K | $17.98 | $600K |
| Oct 28, 2025 | Novo Holdings A/S | 10% Owner | Buy(P) | 953K | $17.00 | $16.2M |
| Oct 28, 2025 | Novo Holdings A/S | 10% Owner | Conversion(C) | 2.7M | — | — |
| Oct 28, 2025 | Novo Holdings A/S | 10% Owner | Conversion(C) | 19.7M | — | $0 |
| Oct 28, 2025 | Novo Holdings A/S | 10% Owner | Conversion(C) | 26.2M | — | $0 |
| Oct 28, 2025 | Kroeger Christopher A. | Chief Executive Officer, Director | Conversion(C) | 4K | — | — |
| Oct 28, 2025 | Kroeger Christopher A. | Chief Executive Officer, Director | Conversion(C) | 65K | — | $0 |
| Oct 28, 2025 | Malenka Robert C. | Director | Conversion(C) | 4K | — | — |
| Oct 28, 2025 | Malenka Robert C. | Director | Conversion(C) | 65K | — | $0 |
| Oct 27, 2025 | Kroeger Christopher A. | Chief Executive Officer, Director | Grant(A) | 226K | — | $0 |
| Oct 27, 2025 | Kroeger Christopher A. | Chief Executive Officer, Director | Grant(A) | 916K | — | $0 |
| Oct 27, 2025 | Gillis Jonathan | CAAO and PAO | Grant(A) | 31K | — | $0 |
| Oct 27, 2025 | Gillis Jonathan | CAAO and PAO | Grant(A) | 124K | — | $0 |
| Oct 27, 2025 | Lillie James Woodruff | Chief Scientific Officer | Grant(A) | 33K | — | $0 |
| Oct 27, 2025 | Lillie James Woodruff | Chief Scientific Officer | Grant(A) | 132K | — | $0 |
| Oct 27, 2025 | Hanson Kristopher | General Counsel | Grant(A) | 27K | — | $0 |
| Oct 27, 2025 | Hanson Kristopher | General Counsel | Grant(A) | 110K | — | $0 |
| Oct 27, 2025 | Walker Maria C | Director | Grant(A) | 6K | — | $0 |
| Oct 27, 2025 | Walker Maria C | Director | Grant(A) | 26K | — | $0 |
| Oct 27, 2025 | Garnett Timothy John | Director | Grant(A) | 6K | — | $0 |
| Oct 27, 2025 | Garnett Timothy John | Director | Grant(A) | 26K | — | $0 |
| Oct 27, 2025 | Malenka Robert C. | Director | Grant(A) | 34K | — | $0 |
| Oct 27, 2025 | Malenka Robert C. | Director | Grant(A) | 140K | — | $0 |
| Oct 27, 2025 | Foff Erin Pennock | Chief Medical Officer | Grant(A) | 48K | — | $0 |
| Oct 27, 2025 | Foff Erin Pennock | Chief Medical Officer | Grant(A) | 196K | — | $0 |
| Oct 27, 2025 | Kreitzer Anatol | Chief Discovery Officer | Grant(A) | 36K | — | $0 |
| Oct 27, 2025 | Kreitzer Anatol | Chief Discovery Officer | Grant(A) | 146K | — | $0 |
| Oct 27, 2025 | Setia Vishwas | Chief Financial Officer | Grant(A) | 43K | — | $0 |
| Oct 27, 2025 | Setia Vishwas | Chief Financial Officer | Grant(A) | 176K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).